Source comparison
Receptor Mechanisms: GHRP-2 vs MK-677 Pathways
GHRP-2 acetate binds directly to the ghrelin receptor (growth hormone secretagogue receptor 1a, or GHS-R1a) on somatotroph cells in the anterior pituitary. This binding triggers intracellular calcium mobilization through the phospholipase C pathway, leading to
This comparison does not assign a generated winner or score.
- GHRP-2 acetate binds directly to the ghrelin receptor (growth hormone secretagogue receptor 1a, or GHS-R1a) on somatotroph cells in the anterior pituitary. This binding triggers intracellular calcium mobilization through the phospholipase C pathway, leading to immediate GH secretion within 15–30 minutes of administration. The peptide's half-life of approximately 30 minutes means plasma GH levels peak sharply and return to baseline within 90–120 minutes. Creating a pulsatile secretion pattern that mirrors the body's natural ultradian GH rhythm.
- MK-677 (ibutamoren) also targets GHS-R1a but does so as a non-peptide mimetic with significantly different pharmacokinetics. Its 24-hour half-life produces sustained receptor occupancy, maintaining elevated GH levels throughout the dosing interval rather than creating discrete pulses. A study in the Journal of Clinical Endocrinology & Metabolism demonstrated that 25mg oral MK-677 increased mean 24-hour GH levels by 97% and IGF-1 by 89% after two weeks. Elevation that persisted without the sharp peaks and troughs characteristic of GHRP-2.
- The mechanistic consequence: GHRP-2 acetate allows precise temporal control over GH secretion, making it preferable for protocols examining pulsatile effects or requiring timed measurements post-administration. MK-677's sustained action simplifies dosing but removes that temporal specificity. You're working with a constant elevation rather than discrete windows.
- Our experience with research teams running parallel protocols shows that the pulsatile vs sustained distinction matters more than most realize. Studies measuring downstream anabolic markers (protein synthesis rates, lipolytic activity) show different kinetic profiles depending on whether GH elevation is pulsed or constant. And that difference isn't always disclosed in supplier marketing materials.